Dual PIKfyve and KRAS-MAPK Inhibition Eradicates Pancreatic Tumors in Preclinical Models

Researchers demonstrate a groundbreaking combination therapy that targets lysosomal recycling and lipid metabolism to overcome pancreatic cancer's resilience.